Source: International Congress 2016 – Sarcoidosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Elżbieta Puścińska (Warsaw, Poland), Elzbieta Puscinska, Anna Goljan Geremek, Elzbieta Radzikowska, Dorota Wyrostkiewicz, Anna Soszka, Adam Nowinski, Michal Bednarek, Pawel Sliwinski. Prevalence of smoking among Polish sarcoid patients. Eur Respir J 2016; 48: Suppl. 60, 826

Member's Comments

No comment yet.

Related content which might interest you: Smoking and interstitial lung diseases Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease Year: 2013 Impact of smoking habit on lung function in a large cohort sarcoidosis patients. Source: International Congress 2014 – Sarcoidosis Year: 2014 Does the HLA-DRB1-genotype influence the course of disease in Danish sarcoidosis patients? Source: Annual Congress 2013 –Sarcoidosis Year: 2013 Prevalence of active smokers among 49 patients affected by interstial lung diseases at two referral centers Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 Genetic analysis of ethnicity of sarcoidosis patients in the Netherlands Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Prevalence and incidence of interstitial lung diseases (ILDs) in a French multi-ethnic county Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Rheumatoid arthritis and comorbid chronic obstructive or interstitial pulmonary diseases: Prevalence in a population-based cohort Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption Year: 2016 Does the BTNL2 genotype influence the course of disease in Danish sarcoidosis patients? Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014 Smoking and interstitial lung diseases Source: Eur Respir Rev 2015; 24: 428-435 Year: 2015 Variation in mortality from interstitial lung disease by diagnosis Source: International Congress 2015 – IIPs: orphan Year: 2015 Childhood pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 COPD in non-smokers: Report from the Tunisian burden of obstructive lung disease study Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Prevalence of pulmonary involvement in rheumatoid arthritis patients in Indian population Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Aetiological panorama in the diagnosis of interstitial lung diseases Source: International Congress 2014 – ILDs 5 Year: 2014 Clinical features of chronic obstructive pulmonary disease in never smokers Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Characteristics and consequences of chronic obstructive pulmonary disease in never smokers Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Risk factors for frequent exacerbations in (ex)smoking and never-smoking adult-onset asthma patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Mortality and survival predictor in chronic hypersensitivity pneumonitis Source: International Congress 2016 – Sarcoidosis Year: 2016 Smoking status and long term clinical outcome in patients with pulmonary Langerhans cell histiocytosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013